Anthera Pharmaceuticals, Inc. (NasdaqCM:ANTH) is seeking acquisitions. The company intends to use the net proceeds to pay off outstanding indebtedness, if any, and/or acquire or invest in complementary businesses, products and technologies. Although the company has no specific agreements, commitments or understandings with respect to any acquisition, it will evaluate acquisition opportunities and engage in related discussions with other companies from time to time. The company also intends to invest the net proceeds in short-term, interest-bearing, investment-grade securities.